Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as diphtheria, hepatitis A, hepatitis B, influenza, Haemophilus influenzae type b (Hib), measles, and mumps. Various government healthcare organizations such as the United Nations Children’s Fund (UNICEF), American Academy of Pediatrics (AAP), and World Health Organization (WHO) are engaged in initiating various immunization awareness programmes to increase vaccination among the pediatric population.
Grab Sample of this Report at: @
Market Dynamics
The Centers for Disease Control and Prevention (CDC) recommends immunizing children against most of the vaccine preventable disease by the time they are two years old. These resulted in elimination of some of the infectious disease completely in various countries. For instance, Polio and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014, World Health Organisation (WHO) declared India as polio-free nation.
Increasing prevalence of chronic and infectious disease, along with growing awareness regarding childhood immunization among various developed and emerging economies lead to boost the growth of pediatric vaccines market in near future. Furthermore, increasing alliances, partnership, and collaborations among key players to introduce
efficient vaccines in the market is expected to drive growth of the market in near future.
Key features of the study:
• This report provides in-depth analysis of pediatric vaccines and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global pediatric vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, pediatric vaccine manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation:
• Global Pediatric Vaccines Market, By Vaccine Type:
o Monovalent
o Multivalent
• Global Pediatric Vaccines Market, By Vaccine Form:
o Attenuated Live Viruses
o Inactivated Viruses
o Subunits
o Toxoids
o Recombinant
o Polysaccharides
o Conjugates
• Global Pediatric Vaccines Market, By Application:
o Infectious Disease
o Allergy
• Global Pediatric Vaccines Market, By End User:
o Hospitals
o Pediatric Clinics
o Research Organizations
o Others
• Global Pediatric Vaccines Market, By Geography:
o North America
o By Country:
• U.S.
• Canada
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
o Europe
o By Country:
• Germany
• France
• Italy
• UK
• Spain
• Russia
• Rest of Europe
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
o Asia Pacific
o By Country:
• China
• India
• Japan
• South Korea
• Australia
• ASEAN
• Rest of Asia Pacific
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
o Middle East
o By Country:
• GCC
• Israel
• Rest of Middle East
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
o Latin America
o By Country:
• Brazil
• Argentina
• Mexico
• Rest of Latin America
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
o Africa
o By Country:
• South Africa
• Central Africa
• North Africa
o By Vaccine Type:
• Monovalent
• Multivalent
o By Vaccine Form:
• Attenuated Live Viruses
• Inactivated Viruses
• Subunits
• Toxoids
• Recombinant
• Polysaccharides
• Conjugates
o By Application
• Infectious Disease
• Allergy
o By End User:
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others
• Company Profiles
o GlaxoSmithKline plc*
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments
o Strategies
o Serum Institute of India Pvt. Ltd.
o Eli Lilly Company
o AstraZeneca plc
o Pfizer, Inc.
o Aventis Pharma Limited
o Indian Immunologicals Limited
o Zydus Cadila
o Panacea Drugs Pvt. Ltd.
o Sinovac Biotech Ltd.
Get Exclusive Discount at: @
“*” marked represents similar segmentation in other categories in the respective section.
Industry Forecast Research 